Announced Tue, 9 Jun · 19:06 IST

Intimation of Appointment of M/s. Kunal Dutt & Associates, Practicing Company Secretaries, Membership No. FCS 8831 as Internal Auditor of the Company.

Management Changes View source PDF

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+8.3%1-day move
₹43.65
prior close
₹43.50
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+1.1-1.1-1.1-1.1+8.3+6.5+1.8+2.2-0.9-1.9-3.3-5.6
Up moveDown movePending
AI summary

Goldline Pharmaceutical Ltd has appointed M/s. Kunal Dutt & Associates, a Practicing Company Secretaries firm (Membership No. FCS 8831), as its Internal Auditor. The appointment was approved by the Board of Directors on June 9, 2026, based on the recommendation of the Audit Committee. It will be effective from the financial year 2026-27 onwards. The firm specialises in corporate law advisory, secretarial audits, compliance management, corporate governance, audit, tax, and regulatory matters. The disclosure confirms the appointed firm is not related to any Director or Key Managerial Personnel of the company.

Likely market impact

This is a routine governance and compliance-related appointment with no material impact on operations or financials. Shareholders should view this as a standard regulatory requirement rather than a catalyst for stock price movement.